New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 14, 2012
10:16 EDTPODDInsulet receives 510(k) clearance for next-generation OmniPod insulin pump
Insulet announced that the company has received 510(k) clearance from the U.S. FDA for the next-generation OmniPod Insulin Management System. The new OmniPod insulin pump is more than one-third smaller and one-quarter lighter than the original model, while maintaining the same 200-unit insulin reservoir capacity and easy-to-use features. In addition to the smaller, lighter Pod, the new OmniPod System includes an updated Personal Diabetes Manager that also features a series of enhancements.
News For PODD From The Last 14 Days
Check below for free stories on PODD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
09:31 EDTPODDInsulet management change suggests takeout unlikely, says Canaccord
Canaccord noted the recent management changes at Insulet and said it suggests it is unlikely an acquisition or takeout of the company is on the horizon. The firm is encouraged by the company's reiteration of guidance and keeps its Buy rating and $39 price target on the stock.
05:49 EDTPODDInsulet CEO change a normal transition, says Piper Jaffray
Subscribe for More Information
September 16, 2014
16:41 EDTPODDInsulet reaffirms FY14 revenue view $290M-$300M, consensus $297.57M
Subscribe for More Information
16:40 EDTPODDInsulet reaffirms Q3 revenue view $73M-$77M, consensus $75.30M
Company expects to record a charge of approximately $8M to $10M in the Q3 to compensation expense, primarily related to the non-cash acceleration of certain equity awards and an additional charge of approximately $3M in the Q4, primarily related to non-cash stock based compensation expense.
16:32 EDTPODDInsulet appoints Patrick Sullivan as CEO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use